192 related articles for article (PubMed ID: 8820069)
1. [Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects].
Galenok VA; Zhuk EA
Ter Arkh; 1995; 67(12):80-4. PubMed ID: 8820069
[No Abstract] [Full Text] [Related]
2. [The characteristics of the immunogenesis and immunocorrection of diabetes mellitus].
Galenok VA; Zhuk EA
Ter Arkh; 1995; 67(10):7-12. PubMed ID: 8779114
[TBL] [Abstract][Full Text] [Related]
3. [The pathogenetic characteristics and the possible ways for the pharmacological correction of insulin-dependent diabetes mellitus].
Chernov IuN; Pashkov AN; Vasin MV; Batishcheva GA; Zolotarev DV
Eksp Klin Farmakol; 1999; 62(3):60-6. PubMed ID: 10439953
[TBL] [Abstract][Full Text] [Related]
4. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
Shishko PI
Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
[No Abstract] [Full Text] [Related]
5. [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?].
Diem P
Ther Umsch; 1993 Feb; 50(2):114-8. PubMed ID: 8456415
[TBL] [Abstract][Full Text] [Related]
6. [Immune modulation therapy in type I diabetes mellitus].
Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
[No Abstract] [Full Text] [Related]
7. Outlook for immune intervention in type I diabetes.
Grob PJ
Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
[No Abstract] [Full Text] [Related]
8. Early intervention in insulin-dependent diabetes mellitus.
Cahill GF
Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
[No Abstract] [Full Text] [Related]
9. The prospects of immunosuppression in type I diabetes.
Bach JF; Feutren G; Boitard C
Adv Nephrol Necker Hosp; 1988; 17():321-40. PubMed ID: 3124546
[No Abstract] [Full Text] [Related]
10. [Role of the immune system in the pathogenesis of type I diabetes (insulin-dependent)].
Hulinský I; Kaslík J; Malý J
Cas Lek Cesk; 1988 Oct; 127(43):1320-4. PubMed ID: 3208274
[No Abstract] [Full Text] [Related]
11. [Thymogen in the treatment of type-1 diabetes mellitus].
Zhuk EA; Galenok VA
Ter Arkh; 1996; 68(10):12-4. PubMed ID: 9026934
[TBL] [Abstract][Full Text] [Related]
12. [Etiology of insulin-dependent diabetes. Prospects for immunological therapy].
Levy-Marchal C; Czernichow P
Ann Pediatr (Paris); 1986 Dec; 33(10):877-81. PubMed ID: 3827098
[No Abstract] [Full Text] [Related]
13. Humoral autoimmune aspects of insulin-dependent (type I) diabetes mellitus.
Dobersen MJ
Concepts Immunopathol; 1985; 2():47-64. PubMed ID: 3916414
[No Abstract] [Full Text] [Related]
14. Hepatitis C virus and type 1 diabetes.
Fallahi P; Di Domenicantonio A; Mazzi V; Santini F; Fabiani S; Sebastiani M; Zignego AL; Ferri C; Antonelli A
Clin Ter; 2013; 164(5):e437-44. PubMed ID: 24217846
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment.
Alfonso B; Liao E; Busta A; Poretsky L
Diabetes Metab Res Rev; 2009 Jul; 25(5):417-9. PubMed ID: 19565622
[TBL] [Abstract][Full Text] [Related]
16. [Diabetes mellitus type 1 (insulin-dependent). The etiopathogenetic aspects (II)].
Guerra Vales JM; Damiano Rivero A
Rev Clin Esp; 1995 Jul; 195(7):485-91. PubMed ID: 7667525
[No Abstract] [Full Text] [Related]
17. [The mechanism of action of immunomodulating preparations ( an analysis of their therapeutic effect in a model of experimental cardiomyopathy].
Groppa LG; Kobets VA; Andreev IuL
Revmatologiia (Mosk); 1991; (3):30-2. PubMed ID: 1812560
[No Abstract] [Full Text] [Related]
18. [Principles and perspectives of immunomodulation in the treatment of diabetes mellitus type I].
Majkowska L; Czekalski S
Pol Tyg Lek; 1989 May 22-29; 44(21-22):509-12. PubMed ID: 2702343
[No Abstract] [Full Text] [Related]
19. [Streptozotocin and viral insulin-dependent diabetes mellitus (autoimmune aspects)].
Poltorak VV; Blokh KO
Probl Endokrinol (Mosk); 1989; 35(3):81-8. PubMed ID: 2668929
[No Abstract] [Full Text] [Related]
20. Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.
Pugliese A
J Clin Invest; 2003 May; 111(9):1280-2. PubMed ID: 12727917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
